{"transactions":[{"id":747901,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001696864-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000169686426000001/primarydocument.xml","form_type":"4"}},{"id":747900,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:06.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":30284,"source":{"system":"sec-edgar","filing":"0001696864-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000169686426000001/primarydocument.xml","form_type":"4"}},{"id":817783,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:41.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015148/ownership.xml","form_type":"4"}},{"id":1119613,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:19:11.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":33393,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":33393},"source":{"system":"sec-edgar","filing":"0001562180-25-004560","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004560/primarydocument.xml","form_type":"4"}},{"id":1122881,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-04T20:23:47.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":999,"price":17.1928,"value":17175.6072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.1025 USD to $17.50 USD; the price reported above reflects the weighted average sale price."}],"balance_after":18674,"source":{"system":"sec-edgar","filing":"0001562180-25-004438","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004438/primarydocument.xml","form_type":"4"}},{"id":1291242,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:08.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004279/ownership.xml","form_type":"4"}},{"id":1488407,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T22:13:53.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders."}],"balance_after":6229,"derivative":{"exercise_price":23.13,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":6229},"source":{"system":"sec-edgar","filing":"0001562180-24-004774","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024004774/primarydocument.xml","form_type":"4"}},{"id":1488406,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-06T22:13:53.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":4053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Report no longer includes indirect ownership of shares held by filer's adult child.  Child no longer shares a residence with the filer."}],"balance_after":19673,"source":{"system":"sec-edgar","filing":"0001562180-24-004774","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024004774/primarydocument.xml","form_type":"4"}},{"id":1749079,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:18.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039527/ownership.xml","form_type":"4"}},{"id":1860483,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:04:47.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":12554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 12,554 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders."}],"balance_after":12554,"derivative":{"exercise_price":48.66,"exercise_date":"2024-06-07","expiration_date":"2033-06-06","underlying":"Ordinary Shares","underlying_shares":12554},"source":{"system":"sec-edgar","filing":"0001562180-23-005014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023005014/primarydocument.xml","form_type":"4"}},{"id":2152285,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:39:39.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026613/ownership.xml","form_type":"4"}},{"id":2235900,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-06-10T20:12:41.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders."}],"balance_after":8700,"derivative":{"exercise_price":77.25,"expiration_date":"2032-06-08","underlying":"Ordinary Shares","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001645113-22-000055","document":"wf-form4_165489194524345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000055/wf-form4_165489194524345.xml","form_type":"4"}},{"id":2550211,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:12:05.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024670/ownership.xml","form_type":"4"}},{"id":2611475,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-06T20:44:16.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":34,"price":153.13,"value":5206.42,"ownership":{"direct":false,"nature":"Indirect"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence.  Mr. Madden disclaims beneficial ownership of these shares."}],"balance_after":384,"source":{"system":"sec-edgar","filing":"0001645113-21-000101","document":"wf-form4_162828263563750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000101/wf-form4_162828263563750.xml","form_type":"4"}},{"id":2671949,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-06-11T20:22:56.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders."}],"balance_after":1499,"derivative":{"exercise_price":211.89,"expiration_date":"2031-06-09","underlying":"Ordinary Shares","underlying_shares":1499},"source":{"system":"sec-edgar","filing":"0001645113-21-000078","document":"wf-form4_162344295339216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000078/wf-form4_162344295339216.xml","form_type":"4"}},{"id":2671948,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-11T20:22:56.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders."}],"balance_after":15620,"source":{"system":"sec-edgar","filing":"0001645113-21-000078","document":"wf-form4_162344295339216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000078/wf-form4_162344295339216.xml","form_type":"4"}},{"id":2808852,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:56:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Indirect"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence.  Mr. Madden disclaims beneficial ownership of these shares."}],"balance_after":418,"source":{"system":"sec-edgar","filing":"0001645113-21-000034","document":"wf-form4_161489857586408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000034/wf-form4_161489857586408.xml","form_type":"4"}},{"id":2988786,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:10.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020843/ownership.xml","form_type":"4"}},{"id":3067496,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-08-05T20:36:18.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Indirect"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence.  Mr. Madden disclaims beneficial ownership of these shares."}],"balance_after":307,"source":{"system":"sec-edgar","filing":"0001645113-20-000117","document":"wf-form4_159665976375408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000117/wf-form4_159665976375408.xml","form_type":"4"}},{"id":3111899,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-06-12T22:09:39.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":5101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 5,101 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders."}],"balance_after":5101,"derivative":{"exercise_price":67.89,"expiration_date":"2030-06-10","underlying":"Ordinary Shares","underlying_shares":5101},"source":{"system":"sec-edgar","filing":"0001645113-20-000088","document":"wf-form4_159199976247040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000088/wf-form4_159199976247040.xml","form_type":"4"}},{"id":3111898,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-12T22:09:39.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders."}],"balance_after":14806,"source":{"system":"sec-edgar","filing":"0001645113-20-000088","document":"wf-form4_159199976247040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000088/wf-form4_159199976247040.xml","form_type":"4"}},{"id":3388915,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:16:26.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015938/ownership.xml","form_type":"4"}},{"id":3511815,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-24T20:13:18.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":6340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 6,340 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders."}],"balance_after":6340,"derivative":{"exercise_price":51.36,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":6340},"source":{"system":"sec-edgar","filing":"0001209191-19-032687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032687/doc4.xml","form_type":"4"}},{"id":3511814,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-24T20:13:18.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":3359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders."}],"balance_after":12265,"source":{"system":"sec-edgar","filing":"0001209191-19-032687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032687/doc4.xml","form_type":"4"}},{"id":3515316,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-22T20:21:37.000Z","date":"2019-05-21","kind":"exercise","acquired":false,"shares":8906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2019-05-21","underlying":"Ordinary Shares","underlying_shares":8906},"source":{"system":"sec-edgar","filing":"0001209191-19-032046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032046/doc4.xml","form_type":"4"}},{"id":3515315,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-22T20:21:37.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":8906,"price":48.87,"value":435236.22,"ownership":{"direct":true},"balance_after":8906,"source":{"system":"sec-edgar","filing":"0001209191-19-032046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032046/doc4.xml","form_type":"4"}},{"id":3689881,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T22:43:39.000Z","date":"2019-01-21","kind":"grant","acquired":true,"shares":2326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2326,"derivative":{"exercise_price":8.6,"expiration_date":"2029-01-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2326},"source":{"system":"sec-edgar","filing":"0001493152-19-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219000862/ownership.xml","form_type":"4"}},{"id":3908482,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-05T00:10:50.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":8906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders."}],"balance_after":8906,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8906},"source":{"system":"sec-edgar","filing":"0001209191-18-035382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919118035382/doc4.xml","form_type":"4"}},{"id":3908481,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-05T00:10:50.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":17891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 17,891 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders."}],"balance_after":17891,"derivative":{"exercise_price":31.45,"expiration_date":"2028-05-31","underlying":"Ordinary Shares","underlying_shares":17891},"source":{"system":"sec-edgar","filing":"0001209191-18-035382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919118035382/doc4.xml","form_type":"4"}},{"id":4138450,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-08T22:09:40.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":38095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":38095,"derivative":{"exercise_price":1.05,"expiration_date":"2027-12-06","underlying":"Common Stock, par value $0.01 per share","underlying_shares":38095},"source":{"system":"sec-edgar","filing":"0001493152-17-014426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014426/form4.xml","form_type":"4"}}]}